New/Revised Product Name Section Changed New

Size: px
Start display at page:

Download "New/Revised Product Name Section Changed New"

Transcription

1 /Revised Product Name Section Changed Chemmart Sumatriptan Zircol Pemzo Clopidogrel RBX Apo-Tramadol Apo-Sumatriptan Acpio Rhophylac Tinasil Clopidogrel-GA Phenasen Acris RiaSTAP Terry White Chemists Sumatriptan Adcirca Bronchitol Fampyra Saizen Solution for Injection Kogenate FS (with Bio-Set) Zoely Tadim Revised Cholvastin Name changed, Precautions, Adverse Reactions Revised Terry White Chemists Frusemide Contraindications, Precautions,, Adverse Reactions Revised Terry White Chemists Sertraline Reactions Revised Cifran Precautions, Interactions with Other, Adverse Reactions Revised GenRx Frusemide Contraindications, Precautions,, Adverse Reactions Revised GenRx Sertraline Reactions Revised Amipride Pregnancy Category Revised Celica Adverse Reactions Revised Rispa Pregnancy Category Revised Kepcet Adverse Revised Chemmart Sertraline Reactions Revised Lactocur Excipients, Indications, Contraindications, Precautions,, Overdosage Revised Sulprix Precautions, Pregnancy Category, Adverse Reactions,

2 Overdosage, Description Revised DBL Sodium Nitroprusside Contraindications, Precautions, Adverse Revised Lipitor Revised DBL Doxorubicin Contraindications, Precautions, Revised DBL Dexamethasone Contraindications, Excipients, Revised Cyprohexal 100 mg Reactions Revised Imigran Revised Cyprohexal 50 mg Reactions Revised Canesoral Other Revised Canesoral Duo Precautions, Interactions with Other, Adverse Reactions Revised Streptase (750,000 IU strength del) Revised Plavix Pharmacology, Precautions, Adverse Reactions, Interactions with Other, Revised Alvesco Revised Flarex Contraindications, Precautions, Adverse Reactions, ARTG Revised Acimax, Adverse Reactions Revised Ultiva for injection Pharmacokinetics Revised Actos Reactions Revised Agrylin Pharmacokinetics, Precautions, Revised Avamys Reactions Revised Relpax Precautions, Revised Celsentri Revised Dilatrend Pharmacology, Pharmacokinetics, Precautions,, Storage Revised Duodopa Name Change, Sponsor Change Revised Efexor XR Precautions Revised Engerix B Vaccine Precautions

3 Revised Eligard Revised Lipidil Company change Revised Engerix B thiomersal free Excipients, Precautions, Dosage and, Revised Zyprexa Relprevv Pregnancy Category Revised Zyprexa IM Pregnancy Category Revised Zanidip Company change, Revised Zan-Extra Company change, Revised Xatral SR Precautions Revised Vesicare Precautions Revised Levlen ED Precautions, Dosage and Revised Kredex Pharmacology, Pharmacokinetics, Precautions, Revised Prothiaden Reinstated product Revised Fasigyn Adverse Reactions Revised Neupogen Precautions Revised Lexapro Precautions, Revised Lamisil Tablets Composition, Interactions with Other, Adverse Reactions, Revised Havrix 1440, Havrix Junior Precautions Revised Havrix 1440, Havrix Junior (Preservative Free) Precautions Revised Implanon Interaction with Other Revised Infanrix IPV (preservative free) Precautions Revised Mencevax ACWY Precautions Revised Sertraline Sandoz name change, Pharmacology, Clinical Trials, Indications, Precautions, Dosage and Revised Microgynon 50 ED Precautions, Interactions with Other,Dosage and Revised Metronide Adverse Reactions Revised Prozac Precautions Revised Eraxis Reactions Revised Emend Adverse Revised Dilzem Company change, Excipients, Revised Cervarix Pharmacology, Clinical Trials, Revised Stelara Contraindications, Precautions,

4 Adverse Reactions Revised Yasmin Precautions Revised Yaz Company change, Precautions,, Revised Albumex 20 Description, Pharmacology, Clinical Trials, Indications,, Storage Revised Berinert Description Revised Simplotan Adverse Reactions Revised Microlevlen ED Company change, Pharmacology, Precautions, Revised Brevibloc (Removal of unmarketed presentation) Revised Intelence Composition, Interactions with Other, (new 200 mg tablet) Revised Isopto Homatropine Description, Contraindications,, (5% del) Revised Logynon ED Company change, Excipients, Other Revised Maxidex Reactions Revised Teveten Composition, Precautions, Adverse Reactions, Revised Teveten Plus Precautions, Revised Microgynon 20 ED Company change, Precautions, Revised Primovist Reactions Revised POTASSIUM CHLORIDE 22.3% (2.23g/10mL) Name Change CONCENTRATED INJECTION Revised Pristiq Precautions Revised Sodium Bicarbonate Description, Pharmacology, Precautions, Interactions with Other, Adverse

5 Revised Sodium Chloride 0.9% (Normal Saline) Sterile Injections and Irrigations Reactions, Overdosage, Storage Pharmacology, Indications, Contraindications, Precautions,, Adverse Reactions, Dosage and, (20% strength added - not avail), Storage Revised Sodium Chloride Sterile Injections 20% & 23.4%, Precautions Revised Triquilar ED Company change, Precautions, Revised Symmetrel Reactions, Overdosage, Revised Seroquel XR Pregnancy Category, Precautions Revised Sandomigran Other, Overdosage Revised Puri-Nethol Precautions, Interactions with Other Revised Flucon Contraindications, Precautions, Adverse Revised Microgynon 30 ED Precautions, Dosage and

new/revised Indapamide-GA

new/revised Indapamide-GA / Indapamide-GA Pharmacor Metformin 500, 850 APO-Metformin Levo/Carbidopa Sandoz Gabapentin Sandoz Levetiracetam SZ Implanon NXT Sodium Chloride Injection 0.9% Eumovate ACTONEL EC, ACTONEL EC COMBI & ACTONEL

More information

new/revised New / Revised Budenofalk Foam Enema CalSource Ca1000 Chemmart Donepezil Doxorubicin SZ Maxigesic Metoclopramide Actavis Metoprolol Actavis

new/revised New / Revised Budenofalk Foam Enema CalSource Ca1000 Chemmart Donepezil Doxorubicin SZ Maxigesic Metoclopramide Actavis Metoprolol Actavis / Budenofalk Foam Enema CalSource Ca1000 Chemmart Donepezil Coperin Doxorubicin SZ Drulox Maxigesic Mekinist Metoclopramide Actavis Metoprolol Actavis Nutrison Opsumit OxyContin Tablets (Reformulated)

More information

New/Revised Product Name Section Changed ANASTROZOLE SANDOZ TABLETS

New/Revised Product Name Section Changed ANASTROZOLE SANDOZ TABLETS /Revised Product Name Section Changed ANASTROZOLE SANDOZ TABLETS ARIANNA Canesten Fungal Nail Treatment Set CARBOPLATIN KABI CIPROFLOXACIN TABLETS Clopidogrel Actavis Clopidogrel Winthrop Plus Aspirin

More information

new/revised New / Revised APOTEX-Pregabalin Auro-Candesartan Candesartan Aspen Candesartan Combi Aspen Candesartan Sandoz Chemmart Montelukast

new/revised New / Revised APOTEX-Pregabalin Auro-Candesartan Candesartan Aspen Candesartan Combi Aspen Candesartan Sandoz Chemmart Montelukast / APOTEX-Pregabalin Auro-Candesartan Candesartan Aspen Candesartan Combi Aspen Candesartan Sandoz Chemmart Montelukast Clavam Famlo Lamotrigine generichealth Latanoprost/Timolol Sandoz Lercanidipine GH

More information

New/Revised Product Name Section Changed

New/Revised Product Name Section Changed New/Revised Product Name Section Changed New Blackmores Acti-Life Protein Powder Plus New Blackmores Bilberry Eyestrain Relief New Blackmores Cal-D New Blackmores Digestive Bio Balance New CADATIN New

More information

New/Revised Product Name Section Changed

New/Revised Product Name Section Changed New/Revised Product Name Section Changed New Abisart New Agiolax New Apo-Ramipril Capsules New Calogen Extra New Candesartan HCTZ-GA New Candesartan-GA New Chemmart Metformin XR New Cholesterol Module

More information

Zylap, Zylap ODT Revised Acimax Tablets Interactions with other medicines, Adverse Reactions Revised Agrippal Contraindications, Adverse

Zylap, Zylap ODT Revised Acimax Tablets Interactions with other medicines, Adverse Reactions Revised Agrippal Contraindications, Adverse /Revised Product Name Section Changed Amlodipine Pfizer Anastrozole Synthon Anastrozole-GA APO-AMISULPRIDE TABLETS Benlysta Beprol Calcitriol-PS Chemmart Anastrozole Escitalopram-GA Femolet Frusemide-PS

More information

New/Revised Product Name Section Changed APO-Omeprazole Capsules

New/Revised Product Name Section Changed APO-Omeprazole Capsules /Revised Product Name Section Changed APO-Omeprazole Capsules Cayston Chemmart Meloxicam Capsules Edurant Incivo Moviprep Novalac Gold Stage 1 Novalac Gold Stage 2 Nupentin Tabs Ocean Guard Cholesterol

More information

New/Revised Product Name Section Changed APO-Riluzole Atenolol GH Atorvastatin SZ

New/Revised Product Name Section Changed APO-Riluzole Atenolol GH Atorvastatin SZ /Revised Product Name Section Changed APO-Riluzole Atenolol GH Atorvastatin SZ Bydureon Cefazolin-AFT Ceftriaxone Alphapharm Ceftriaxone-AFT Clobex Dimetapp PE Day + Night Cough Cold + Flu Endometrin Fortisip

More information

Adverse Reactions. Precautions, Interactions with other medicines, Adverse Reactions. Adverse Reactions. Precautions, Adverse Reactions

Adverse Reactions. Precautions, Interactions with other medicines, Adverse Reactions. Adverse Reactions. Precautions, Adverse Reactions New Yervoy New Eliquis New Saphris Lisinopril-GA Company name changed Fluoxetine-GA, Interactions with other medicines Tramadol Sandoz SR APO-Bicalutamide,, Amisulpride Winthrop Apo-Fluvoxamine Contraindications,,

More information

New Lercanidipine Sandoz New Amiodarone Sandoz New Acetec New Vancomycin Alphapharm New Chemmart Levetiracetam New Cephazolin Alphapharm New

New Lercanidipine Sandoz New Amiodarone Sandoz New Acetec New Vancomycin Alphapharm New Chemmart Levetiracetam New Cephazolin Alphapharm New New/Revised Product Name New Lercanidipine Sandoz New Amiodarone Sandoz New Acetec New Vancomycin Alphapharm New Chemmart Levetiracetam New Cephazolin Alphapharm New APO-Prochlorperazine New Apo-Perindopril

More information

New/Revised Product Name Section Changed

New/Revised Product Name Section Changed New/Revised Product Name Section Changed New Aciclovir GH New Advil Childrens 7-12 Years Chewable Tablets New Advil Children's Chewable 2-7 Years New APO-Galantamine MR New APO-Mycophenolate Capsules New

More information

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Table 1: Price increases for Brand Name Drugs with Generic Equivalents Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%

More information

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE

PBS PRICE INCREASES - AUGUST 2014 SCHEDULE Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M

More information

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML)

Section H. Pharmaceuticals. New Zealand Pharmaceutical Schedule. Effective 1 July for Hospital. The Hospital Medicines List (HML) The Hospital Medicines List (HML) Section H for Hospital Management Agency Pharmaceuticals Update Update effective 1 August 2014 New Zealand Pharmaceutical Schedule Effective 1 July 2013 Cumulative for

More information

ADT Booster Product Information

ADT Booster Product Information NAME OF THE MEDICINE ADT Booster. Diphtheria and Tetanus Vaccine (adsorbed) for revaccination. DESCRIPTION ADT Booster is a suspension for intramuscular injection, containing aluminium-hydroxide-adsorbed

More information

ADT Booster Data Sheet

ADT Booster Data Sheet 1. PRODUCT NAME ADT Booster. Diphtheria and Tetanus Vaccine (adsorbed) for revaccination. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ADT Booster is a suspension for intramuscular injection, containing

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Sterile Potassium Chloride Concentrate 15%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15% of Potassium Chloride in

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) I.P. Injectable, Suspension for injection. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 0.5 ml contains:

More information

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed.

Instil one or two drops in the conjunctival sac(s) every three to four hours as needed. NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON FORTE Eye Drops 0.1% 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon Forte contains naphazoline hydrochloride 1.0 mg in 1 ml (0.1%). Excipient with known

More information

MENCEVAX ACWY PRODUCT INFORMATION

MENCEVAX ACWY PRODUCT INFORMATION MENCEVAX ACWY PRODUCT INFORMATION Group A, C, W-135 and Y polysaccharide meningococcal vaccine NAME OF THE MEDICINE Mencevax ACWY meningococcal polysaccharide vaccine DESCRIPTION Mencevax ACWY is a lyophilized

More information

1. TRADE NAME OF THE MEDICINAL PRODUCT

1. TRADE NAME OF THE MEDICINAL PRODUCT 1. TRADE NAME OF THE MEDICINAL PRODUCT IGANTET 250 I.U. solution for injection in pre-filled syringe IGANTET 500 I.U. solution for injection in pre-filled syringe 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

Mencevax ACWY. 1 Name of the medicinal product Mencevax ACWY.

Mencevax ACWY. 1 Name of the medicinal product Mencevax ACWY. Mencevax ACWY 1 Name of the medicinal product Mencevax ACWY. 2 Qualitative and Quantitative Composition Mencevax ACWY is a lyophilized, preparation of purified polysaccharides from Neisseria meningitidis

More information

NEW ZEALAND DATA SHEET 1. PRODUCT NAME

NEW ZEALAND DATA SHEET 1. PRODUCT NAME NEW ZEALAND DATA SHEET 1. PRODUCT NAME Flucon fluorometholone 0.1% Eye Drops Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Flucon contains 1.0 mg of fluorometholone (0.1% w/v). Excipient

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. Name of the product: 1.1 Product name: EQUIRAB Rabies Antiserum - Equine 1.2 Strength: 1000 I.U. / 5 ml 1.3 Pharmaceutical Dosage form: Injection 2. Qualitative and

More information

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION

DBL MAGNESIUM SULFATE CONCENTRATED INJECTION DBL MAGNESIUM SULFATE CONCENTRATED INJECTION NAME OF MEDICINE Magnesium Sulfate BP DESCRIPTION DBL Magnesium Sulfate Concentrated Injection is a clear, colourless, sterile solution. Each ampoule contains

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobilis OR inac emulsion for injection for chickens 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Per dose of 0.25

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET 1 ONDANSETRON-CLARIS 2 mg/ml solution for injection Ondansetron-Claris Solution for Injection 2 mg/ml 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ondansetron-Claris, Solution for Injection, is a clear colourless

More information

MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350)

MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350) MOVICOL Liquid Orange Flavour Concentrate for Oral Solution (macrogol 3350) NAME OF THE MEDICINE: MOVICOL Liquid Orange Flavour, Concentrate for Oral Solution. DESCRIPTION: A clear colourless solution.

More information

DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION DATA SHEET 1 PRODUCT NAME 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Sachet, each 5.1g sachet contains: Sodium chloride 470mg, potassium chloride 300mg, sodium acid citrate 530mg, glucose 3.56g. Tablet,

More information

DBL NALOXONE HYDROCHLORIDE INJECTION USP

DBL NALOXONE HYDROCHLORIDE INJECTION USP Name of medicine Naloxone hydrochloride Data Sheet New Zealand DBL NALXNE HYDRCHLRIDE INJECTIN USP Presentation DBL Naloxone Hydrochloride Injection USP is a sterile, clear, colourless solution, free from

More information

MINIMS AMETHOCAINE EYE DROPS

MINIMS AMETHOCAINE EYE DROPS MINIMS AMETHOCAINE EYE DROPS NAME OF THE MEDICINE Amethocaine hydrochloride Synonyms: Tetracaine hydrochloride Structural formula: Chemical name: 2-(dimethylamino)ethyl 4-(butylamino)benzoate hydrochloride

More information

SUMMARY OF PRODUCT CHARACTRISTICS

SUMMARY OF PRODUCT CHARACTRISTICS 1. NAME OF THE MEDICINAL PRODUCT Purified, Inactivated, Lyophilized Rabies Vaccine, Prepared on Vero Cells INDIRAB 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative Formula per dose of 0.5 ml (Single

More information

PRODUCT INFORMATION. DESCRIPTION Addaven is a concentrated trace element solution for infusion which is clear and colourless to slightly yellow.

PRODUCT INFORMATION. DESCRIPTION Addaven is a concentrated trace element solution for infusion which is clear and colourless to slightly yellow. PRODUCT INFORMATION Addaven NAME OF MEDICINE Addaven is a concentrated trace element solution containing the following simple salts: chromic chloride hexahydrate (CAS No.:10060-12-5), cupric chloride dihydrate

More information

New Zealand Data Sheet COLISTIN-LINK

New Zealand Data Sheet COLISTIN-LINK New Zealand Data Sheet COLISTIN-LINK Colistimethate sodium equivalent to colistin 150mg powder for injection For intramuscular and intravenous use. Description Colistimethate sodium for injection, USP

More information

Vaccine Label Examples

Vaccine Label Examples Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can

More information

AUSTRALIAN PRODUCT INFORMATION SOFRADEX (FRAMYCETIN SULFATE, GRAMICIDIN AND DEXAMETHASONE (AS SODIUM METASULFOBENZOATE))

AUSTRALIAN PRODUCT INFORMATION SOFRADEX (FRAMYCETIN SULFATE, GRAMICIDIN AND DEXAMETHASONE (AS SODIUM METASULFOBENZOATE)) AUSTRALIAN PRODUCT INFORMATION SOFRADEX (FRAMYCETIN SULFATE, GRAMICIDIN AND DEXAMETHASONE (AS SODIUM METASULFOBENZOATE)) 1 NAME OF THE MEDICINE Sofradex (framycetin sulfate, gramicidin and dexamethasone

More information

DATA SHEET QUALITATIVE AND QUANTITATIVE COMPOSITION

DATA SHEET QUALITATIVE AND QUANTITATIVE COMPOSITION 1 DATA SHEET PRODUCT NAME Solution for injection 1 mg/ml QUALITATIVE AND QUANTITATIVE COMPOSITION Hydroxocobalamin acetate 1 mg/ml For full list of excipients, see section 6.1 PHARMACEUTICAL FORM Solution

More information

PRODUCT INFORMATION RESONIUM A. Na m

PRODUCT INFORMATION RESONIUM A. Na m PRODUCT INFORMATION RESONIUM A NAME OF THE MEDICINE Non-proprietary Name Sodium polystyrene sulfonate Chemical Structure CH - 2 CH SO 3 Na + n CAS Number 28210-41-5 [9003-59-2] CH 2 CH SO - 3 m DESCRIPTION

More information

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION

AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION AUSTRALIAN PRODUCT INFORMATION FLAREX (FLUOROMETHOLONE ACETATE) EYE DROPS SUSPENSION 1 NAME OF THE MEDICINE Fluorometholone acetate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The active ingredient in

More information

Solution for cardiac perfusion in viaflex plastic container

Solution for cardiac perfusion in viaflex plastic container CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac

More information

Public Case Detail. Case Number : Reaction : Medicine details : Cases Count: 15. Gender : Weight (kg) : 36Y. Hospitalisation : Age :

Public Case Detail. Case Number : Reaction : Medicine details : Cases Count: 15. Gender : Weight (kg) : 36Y. Hospitalisation : Age : Case Number : 231711 9/8/27 M 36Y Unknown Urticaria Reason : Tablet 4 Milligram 2 times Oral CITALOPRAM HYDROBROMIDE (Other drug) Reason : 4 Milligram Oral PUTRAN2 Page 1 of 18 Case Number : 233954 M 3/1/27

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Citanest with Octapressin Dental 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains Prilocaine Hydrochloride 30 mg (54 mg/1.8

More information

MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350)

MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350) MOVICOL Lemon-Lime Flavour Powder for Solution (macrogol 3350) Product Name: MOVICOL Lemon-Lime Flavour Product Description: Each sachet of MOVICOL Lemon-Lime contains: Macrogol 3350 Sodium chloride Sodium

More information

Vaccine Label Examples

Vaccine Label Examples Vaccine Label Examples With the large amount of vaccine carried in most clinics, staff can easily become confused about vaccines within the storage unit. Labeling the area where vaccines are stored can

More information

TYPHERIX PRODUCT INFORMATION (Salmonella typhi Vi polysaccharide)

TYPHERIX PRODUCT INFORMATION (Salmonella typhi Vi polysaccharide) TYPHERIX PRODUCT INFORMATION (Salmonella typhi Vi polysaccharide) DESCRIPTION TYPHERIX is a colourless, sterile liquid containing the cell surface Vi polysaccharide extracted from Salmonella typhi Ty2

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION NEW ZEALAND DATA SHEET 1. PRODUCT NAME ISOPTO CARPINE pilocarpine hydrochloride eye drops 1% ISOPTO CARPINE pilocarpine hydrochloride eye drops 2% ISOPTO CARPINE pilocarpine hydrochloride eye drops 4%

More information

ZOFRAN INJECTION GlaxoSmithKline

ZOFRAN INJECTION GlaxoSmithKline ZOFRAN INJECTION GlaxoSmithKline Ondansetron QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1 ml of aqueous solution contains 2 mg ondansetron as hydrochloride dihydrate. PHARMACEUTICAL FORM A clear, colourless,

More information

Health Products Regulatory Authority

Health Products Regulatory Authority 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Suvaxyn M.hyo - Parasuis, suspension for injection for pigs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances: per 2 ml dose Inactivated Mycoplasma

More information

BOOSTRIX. Combined diphtheria, tetanus, acellular pertussis vaccine

BOOSTRIX. Combined diphtheria, tetanus, acellular pertussis vaccine BOOSTRIX Combined diphtheria, tetanus, acellular pertussis vaccine QUALITATIVE AND QUANTITATIVE COMPOSITION 1 dose (0.5 ml) contains: Diphtheria toxoid 1 Tetanus toxoid 1 Bordetella pertussis antigens

More information

Pentabio Vaccine (DTP-HB-Hib)

Pentabio Vaccine (DTP-HB-Hib) SUMMARY OF PRODUCT CHARACTERISTICS Product Name Pharmaceutical Form Strength Presentation : Pentabio : Suspension for injection : 1, 5 and 10 doses : Box of 10 vials @ 0.5 ml Box of 10 vials @ 2.5 ml Box

More information

AUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM

AUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM AUSTRALIAN PRODUCT INFORMATION APO-BETAHISTINE (BETAHISTINE DIHYDROCHLORIDE) 1 NAME OF THE MEDICINE Betahistine dihydrochloride. 2 AND 3 QUALITATIVE AND QUANTITATIVE COMPOSITION AND PHARMACEUTICAL FORM

More information

To: Director-general, Department of Health, Prefectural Governments. Points to Consider for the Instructions for Package Inserts of Prescription Drugs

To: Director-general, Department of Health, Prefectural Governments. Points to Consider for the Instructions for Package Inserts of Prescription Drugs Translated by PhRMA Japan (Pharmaceutical Research and Manufacturers of America Japan) and EFPIA Japan (European Federation of Pharmaceutical Industries and Associations Japan) with consultation to MHLW

More information

Meningococcal polysaccharide vaccine Group A, Group C, Group Y and Group W-135

Meningococcal polysaccharide vaccine Group A, Group C, Group Y and Group W-135 MENOMUNE ACYW-135 Meningococcal polysaccharide vaccine Group A, Group C, Group Y and Group W-135 Description The vaccine is a freeze-dried preparation of the group specific antigens from Neisseria meningitidis,

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION Summary of Product Characteristics 1. NAME OF THE MEDICINAL PRODUCT {To be completed nationally} 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 mg tablets: each tablet contains 1 mg granisetron (as hydrochloride).

More information

NEW ZEALAND DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

NEW ZEALAND DATA SHEET 2 QUALITATIVE AND QUANTITATIVE COMPOSITION NEW ZEALAND DATA SHEET 1 PRODUCT NAME SOFRADEX, Ear/Eye Drops 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of drops contains framycetin sulfate 5mg, gramicidin 0.05mg and dexamethasone 0.5mg. For

More information

christmas & new year sale

christmas & new year sale 6 49 9 99 christmas & new year sale December 2009 & January 2010 2 49 Nivea Sun Light Feel SPF 30+ 125ml Nivea Sun Spray SPF 30+ 200ml Also Availabe SPF15+ Spray 200ml $9.69 Redwin Vitamin E Cream 300g

More information

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA

ABILIFY ABILIFY DISCMELT ACTONEL ACTOPLUS MET ACTOPLUS MET XR ACTOS ADCIRCA ADVAIR DISKUS ADVAIR HFA Quantity Limits Paramount Medicare Formulary 2012 Formulary ID 12112, Version 22. CMS Approved 10-23-2012. ABILIFY Abilify TABS ABILIFY DISCMELT Abilify Discmelt ACTONEL Actonel TABS 150MG Actonel TABS

More information

Havrix 1440 Adult / 720 Junior Inactivated hepatitis A vaccine

Havrix 1440 Adult / 720 Junior Inactivated hepatitis A vaccine Proposed Package Insert (updated 1Jun12) Havrix 1440 Adult / 720 Junior Inactivated hepatitis A vaccine QUALITATIVE AND QUANTITATIVE COMPOSITION Suspension for injection. One dose (1.0 ml) of Havrix 1440

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET 1 PRODUCT NAME CALCIUM FOLINATE SANDOZ 10mg/mL; concentrate for injection 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of Calcium Folinate Sandoz, concentrate for injection contains 10 mg folinic

More information

Our patients need the below listed medications, which we do not have available.

Our patients need the below listed medications, which we do not have available. The Metropolitan Community Clinic at Hellinikon provides FREE medical assistance to the UNEMPLOYED and POOR civilians with NO SOCIAL SECURITY or with very little income. So many have asked us lately, what

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Circovac emulsion and suspension for emulsion for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

More information

This is a purified, inactivated, split virion (split virus) vaccine each 0.5 ml of which contains antigens representative of the following types:

This is a purified, inactivated, split virion (split virus) vaccine each 0.5 ml of which contains antigens representative of the following types: Fluvax WARNING: This season s vaccine is indicated for use only in persons aged 5 years and over. It must not be used in children under 5 years (see Contraindications). It should only be used in children

More information

CLINICAL PHARMACOLOGY INFANRIX DTPa vaccine, induces antibodies against all vaccine components.

CLINICAL PHARMACOLOGY INFANRIX DTPa vaccine, induces antibodies against all vaccine components. INFANRIX PRODUCT INFORMATION NAME OF THE MEDICINE Diphtheria-tetanus-acellular pertussis (DTPa) vaccine DESCRIPTION INFANRIX DTPa vaccine is a sterile suspension which contains diphtheria toxoid, tetanus

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT "Carbellon" Tablets. 2. Qualitative and Quantitative Composition Active Constituents: Activated Charcoal Ph.Eur. Magnesium Hydroxide Ph.Eur.

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 3 Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredients Sodium Chloride Glucose Anhydrous

More information

Package leaflet: Information for the user

Package leaflet: Information for the user 8U004E Package leaflet: Information for the user DT Diphtheria-tetanus vaccine adsorbed suspension for injection Diphtheria and tetanus vaccine, adsorbed Tetanus toxoid not less than 40 IU and diphtheria

More information

Public Assessment Report Scientific discussion. Sumatriptan Pfizer (sumatriptan succinate) SE/H/973/01-02/DC

Public Assessment Report Scientific discussion. Sumatriptan Pfizer (sumatriptan succinate) SE/H/973/01-02/DC Public Assessment Report Scientific discussion Sumatriptan Pfizer (sumatriptan succinate) SE/H/973/01-02/DC This module reflects the scientific discussion for the approval of Sumatriptan Pfizer. The procedure

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Charcodote 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Activated charcoal 200mg/ml 3. PHARMACEUTICAL FORM Oral suspension 4. CLINICAL

More information

Summary of Product Characteristics

Summary of Product Characteristics Summary of Product Characteristics 1) NAME OF THE MEDICINAL PRODUCT Meningococcal A conjugate vaccine 5 micrograms, Lyophilized Brand name- MenAfriVac 2) QUALITATIVE AND QUANTITATIVE COMPOSITION After

More information

Summary of Changes to the Alberta Human Services Drug Benefit Supplement

Summary of Changes to the Alberta Human Services Drug Benefit Supplement Summary of Changes to the Alberta Human Services Drug Benefit Supplement Effective April 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J

More information

Artesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6

Artesunate 120mg powder for injection (Guilin Pharmaceutical Co., Ltd), MA90 LABELLING. Page 1 of 6 LABELLING Page 1 of 6 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Outer Carton 1. NAME OF THE MEDICINAL PRODUCT Artesun 120mg * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 120 mg artesunate powder

More information

PRODUCT INFORMATION. Colistin Link. Colistin 150 mg/2 ml (as colistimethate sodium) powder for injection vial

PRODUCT INFORMATION. Colistin Link. Colistin 150 mg/2 ml (as colistimethate sodium) powder for injection vial PRODUCT INFORMATION Colistin Link Colistin 150 mg/2 ml (as colistimethate sodium) powder for injection vial For Intramuscular and Intravenous use. NAME OF THE MEDICINE Colistimethate sodium for injection,

More information

WHO PACKAGE INSERT. GlaxoSmithKline Biologicals FluLaval. Dossier First - Chapter 1 to 10 for WHO

WHO PACKAGE INSERT. GlaxoSmithKline Biologicals FluLaval. Dossier First - Chapter 1 to 10 for WHO 77 WHO PACKAGE INSERT 11 Chapter 4_Annex 4.4-1_ WHO leaflet_en - Page 1 78 1. NAME OF THE MEDICINAL PRODUCT, suspension for injection Influenza vaccine (split virion, inactivated) 2. QUALITATIVE AND QUANTITATIVE

More information

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients:

2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution contains the following active ingredients: SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Macrovic Junior powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet of Macrovic Junior powder for oral solution

More information

Drugs That Have Quantitiy Limits (QL)

Drugs That Have Quantitiy Limits (QL) Drugs That Have Quantitiy Limits (QL) There are Quantity Limits set by your UA Medicare Group Part D Prescription Drug Plan for the drugs listed below. The UA Medicare Group Part D Prescription Drug Plan

More information

IMPORTANT: PLEASE READ

IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine This leaflet is part III of a three-part "Product Monograph" published when was approved for sale

More information

PRODUCT INFORMATION INFLUVAC. NAME OF THE MEDICINE Influvac inactivated influenza vaccine (surface antigen)

PRODUCT INFORMATION INFLUVAC. NAME OF THE MEDICINE Influvac inactivated influenza vaccine (surface antigen) PRODUCT INFORMATION INFLUVAC NAME OF THE MEDICINE Influvac inactivated influenza vaccine (surface antigen) DESCRIPTION Influvac is a clear colourless suspension for injection. It is an egg-grown, inactivated

More information

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. NEW ZEALAND DATA SHEET 1. PRODUCT NAME NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Naphcon-A contains naphazoline hydrochloride

More information

NEW ZEALAND DATA SHEET

NEW ZEALAND DATA SHEET 1. PRODUCT NAME ADDAVEN (infusion, solution concentrate) NEW ZEALAND DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 10 ml ampoule of Addaven contains: Chromic chloride hexahydrate 53.33 µg

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT BioEquin H, emulsion for injection for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One vaccine dose (1 ml) contains:

More information

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zaditen 0.25 mg/ml, eye drops, solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One ml contains 0.345 mg ketotifen fumarate corresponding

More information

PRODUCT INFORMATION INFLUVAC. NAME OF THE MEDICINE Influvac inactivated influenza vaccine (surface antigen)

PRODUCT INFORMATION INFLUVAC. NAME OF THE MEDICINE Influvac inactivated influenza vaccine (surface antigen) PRODUCT INFORMATION INFLUVAC NAME OF THE MEDICINE Influvac inactivated influenza vaccine (surface antigen) DESCRIPTION Influvac is a clear colourless suspension for injection. It is an egg-grown, inactivated

More information

MOVICOL Junior Powder for Solution (macrogol 3350)

MOVICOL Junior Powder for Solution (macrogol 3350) MOVICOL Junior Powder for Solution (macrogol 3350) Product Name: MOVICOL Junior Product Description: Each sachet of MOVICOL Junior contains: Macrogol 3350 Sodium chloride Sodium bicarbonate Potassium chloride

More information

ROSOBAC-1GM / ROSOBAC-FORT

ROSOBAC-1GM / ROSOBAC-FORT ROSOBAC-1GM / ROSOBAC-FORT ROSOBAC - 1GM. COMPOSITION : Each vial contains Sterile Cefoperazone Sodium IP Eq. to Anhydrous Cefoperazone - Sterile Sulbactam Sodium USP Eq. to Anhydrous Sulbactam - ROSOBAC

More information

MENCEVAX ACWY PRODUCT INFORMATION

MENCEVAX ACWY PRODUCT INFORMATION MENCEVAX ACWY PRODUCT INFORMATION Group A, C, W135 and Y polysaccharide meningococcal vaccine DESCRIPTION MENCEVAX ACWY is a lyophilized preparation of purified polysaccharides from Neisseria meningitidis

More information

DBL LEUCOVORIN CALCIUM INJECTION USP AND TABLETS

DBL LEUCOVORIN CALCIUM INJECTION USP AND TABLETS DBL LEUCOVORI CALCIUM IJECTIO USP AD TABLETS ame of medicine Calcium folinate Presentation DBL Leucovorin Calcium Injection USP is a sterile solution of folinic acid (as calcium salt) in water for injections.

More information

Approval / Acknowledgement Letter Ref No. / Diary no F.No.12-48/GSK/PAC- Synflorix/15-BD 25-Mar-15 2 GlaxoSmithKline Pharmaceuticals Limited.

Approval / Acknowledgement Letter Ref No. / Diary no F.No.12-48/GSK/PAC- Synflorix/15-BD 25-Mar-15 2 GlaxoSmithKline Pharmaceuticals Limited. 1 GlaxoSmithKline Deletion of a n-significant in-process test limit during the purification process of the tetanus / diphtheria toxoids used in the manufacture of GSK's PCV vaccine [brand name: Synflorix]

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Nobivac L4, suspension for injection for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:

More information

Pharmacy Costs: Can I Make a Difference?

Pharmacy Costs: Can I Make a Difference? Pharmacy Costs: Can I Make a Difference? Pharmaceutical Market Dynamics What is driving Rx cost up? No New Blockbusters Patent Expirations OTC Market Dynamics Availability Pharmaceutical Companies Unfortunately,

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT RESPIPORC FLUpan H1N1 suspension for injection for pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of

More information

SUMMARY OF THE PRODUCT CHARACTERISTICS. The content of electrolyte ions per sachet when made up to 125 ml of solution.

SUMMARY OF THE PRODUCT CHARACTERISTICS. The content of electrolyte ions per sachet when made up to 125 ml of solution. SUMMARY OF THE PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Molaxole powder for oral solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains following active substances Macrogol

More information

Fluvax vaccine 2013 (AUST R 91583, AUST R and AUST R ) 0.5 ml and 10 x 0.5 ml presentations October 2012

Fluvax vaccine 2013 (AUST R 91583, AUST R and AUST R ) 0.5 ml and 10 x 0.5 ml presentations October 2012 Fluvax WARNING: This season s vaccine is indicated for use only in persons aged 5 years and over. It must not be used in children under 5 years (see Contraindications). It should only be used in children

More information

For a full list of excipients, see section 6.1. A sterile, clear, bright, colourless, aqueous solution.

For a full list of excipients, see section 6.1. A sterile, clear, bright, colourless, aqueous solution. SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sofradex Ear/Eye Drops, Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each bottle contains 0.5% w/v of Framycetin Sulphate, Dexamethasone

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Synthamin 14, 8.5% Amino Acid Intravenous Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION L-Leucine Ph. Eur 0.620% w/v L-Isoleucine

More information

B. PACKAGE LEAFLET. Page 1 of 6

B. PACKAGE LEAFLET. Page 1 of 6 B. PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET Prilocard 1.25 mg, 2.5 mg, 5 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE

More information

DESCRIPTION Locacorten-Vioform ear drops are a practically odourless clear, yellowish to brownish-yellow solution. Excipients: Macrogol 300

DESCRIPTION Locacorten-Vioform ear drops are a practically odourless clear, yellowish to brownish-yellow solution. Excipients: Macrogol 300 PRODUCT INFORMATION LOCACORTEN -VIOFORM Ear Drops NAME OF THE MEDICINE Flumethasone pivalate Chemical formula: C 27 H 36 F 2 O 6 (6α, 9-Difluouro-11β,17,21-trihydroxy-16α-methyl-pregna- 1,4-diene-3,20-dione

More information

Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV)

Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV) Diphtheria-Tetanus-Acellular Pertussis-Polio- Combined Vaccine Biological Page (DTaP-IPV) Section 7: Biological Product Information Standard #: 07.212 Created by: Province-wide Immunization Program Standards

More information

Artesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING

Artesunate 60 mg for injection WHOPAR part 5 June 2013 (Guilin Pharmaceutical Co., Ltd.), MA051 LABELLING LABELLING 1 PARTICULARS TO APPEAR ON THE OUTER PACKAGING Carton (pack of 1 vial and 2 ampoules) 1. NAME OF THE MEDICINAL PRODUCT Artesun * 2. STATEMENT OF ACTIVE SUBSTANCE Each vial contains 60 mg artesunate

More information

Please see accompanying Full Prescribing Information.

Please see accompanying Full Prescribing Information. To Help Restore Joint Function Adequan i.m. is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock

More information